1.
Carles J, Domenech M, Gelabert-Mas A, Nogue M, Tabernero JM, Arcusa A, et al. Phase II Study of Estramustine and Vinorelbine in Hormone-Refractory Prostate Carcinoma Patients. AO [Internet]. 1998 Jan. 1 [cited 2025 Feb. 21];37(2):187-91. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/28476